Dharamvir Jain

1.7k total citations
28 papers, 474 citations indexed

About

Dharamvir Jain is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dharamvir Jain has authored 28 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dharamvir Jain's work include Breast Cancer Treatment Studies (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Global Cancer Incidence and Screening (4 papers). Dharamvir Jain is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Global Cancer Incidence and Screening (4 papers). Dharamvir Jain collaborates with scholars based in United States, India and Canada. Dharamvir Jain's co-authors include Anthony E. Dragun, N. Shesh, Jianmin Pan, Elizabeth C. Riley, Cesar A. Perez, Chuanlin Ding, Teresa W.‐M. Fan, Sabrin Albeituni, Yihua Cai and Jun Yan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Dharamvir Jain

26 papers receiving 465 citations

Peers

Dharamvir Jain
Gianfranco Zannoni Italy
Xi Cheng China
Shanique Martin United States
Silverio Tomao Italy
Zhifeng Xi China
Kakil Ibrahim Rasul Qatar
Musa Altun Türkiye
Kohji Yoshida Japan
Oxana V. Makarova‐Rusher United States
Giuseppa Scandurra Italy
Gianfranco Zannoni Italy
Dharamvir Jain
Citations per year, relative to Dharamvir Jain Dharamvir Jain (= 1×) peers Gianfranco Zannoni

Countries citing papers authored by Dharamvir Jain

Since Specialization
Citations

This map shows the geographic impact of Dharamvir Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharamvir Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharamvir Jain more than expected).

Fields of papers citing papers by Dharamvir Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharamvir Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharamvir Jain. The network helps show where Dharamvir Jain may publish in the future.

Co-authorship network of co-authors of Dharamvir Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Dharamvir Jain. A scholar is included among the top collaborators of Dharamvir Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharamvir Jain. Dharamvir Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Owen, Dwight H., Navneet Singh, Nofisat Ismaila, et al.. (2022). Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Journal of Clinical Oncology. 41(5). e1–e9. 17 indexed citations
3.
Bhandari, Shruti, et al.. (2019). Adherence to anti-estrogen therapy in women with hormone receptor-positive breast cancer utilizing bubble packaging: a pilot study. Breast Cancer Research and Treatment. 177(2). 395–399. 4 indexed citations
4.
Bhandari, Shruti, et al.. (2018). Management of immunotherapy toxicities in older adults. Seminars in Oncology. 45(4). 226–231. 24 indexed citations
5.
Dragun, Anthony E., Elizabeth C. Riley, Teresa L. Roberts, et al.. (2017). First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(3). 595–602. 19 indexed citations
6.
Perez, Cesar A., Mark J. Amsbaugh, Wederson M. Claudino, et al.. (2017). High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck. Oral Oncology. 67. 24–28. 11 indexed citations
7.
Jain, Dharamvir, et al.. (2016). Age-related Disparity: Breast Cancer in the Elderly. Current Oncology Reports. 18(11). 69–69. 28 indexed citations
8.
Dias, Ajoy, Wederson M. Claudino, Rahul Sinha, Cesar A. Perez, & Dharamvir Jain. (2016). Human epidermal growth factor antagonists and cardiotoxicity—A short review of the problem and preventative measures. Critical Reviews in Oncology/Hematology. 104. 42–51. 10 indexed citations
9.
10.
Dias, Ajoy & Dharamvir Jain. (2014). Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition. Cardiovascular & Hematological Agents in Medicinal Chemistry. 11(4). 265–271. 6 indexed citations
11.
Dunlap, Neal, et al.. (2014). Efficacy of Concurrent Chemoradiotherapy for Patients With Locally Recurrent or Advanced Inoperable Breast Cancer. Clinical Breast Cancer. 15(2). 135–142. 12 indexed citations
12.
Barry, Parul, Elizabeth C. Riley, Jianmin Pan, et al.. (2013). Delay of Adjuvant Chemotherapy After Elective Mastectomy and Immediate Reconstruction in Breast-conservation Candidates. American Journal of Clinical Oncology. 37(6). 575–579. 19 indexed citations
13.
Dragun, Anthony E., Jianmin Pan, Elizabeth C. Riley, et al.. (2012). Increasing Use of Elective Mastectomy and Contralateral Prophylactic Surgery Among Breast Conservation Candidates. American Journal of Clinical Oncology. 36(4). 375–380. 58 indexed citations
14.
Dragun, Anthony E., Amy R. Quillo, Elizabeth C. Riley, et al.. (2012). A Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation: First Report of Acute Toxicity, Feasibility, and Patient Satisfaction. International Journal of Radiation Oncology*Biology*Physics. 85(3). e123–e128. 28 indexed citations
15.
Dragun, Anthony E., et al.. (2010). Locoregional Recurrence in Patients With Triple-Negative Breast Cancer. American Journal of Clinical Oncology. 34(3). 231–237. 30 indexed citations
16.
Malone, Janine C., et al.. (2009). Leukaemia cutis in a patient treated for breast cancer. Australasian Journal of Dermatology. 50(1). 52–55. 3 indexed citations
17.
Jain, Dharamvir, et al.. (2009). SP-D Modulates Alveolar Macrophage Polarization and Activation.. A6270–A6270. 2 indexed citations
18.
Malone, Janine C., et al.. (2008). Therapy‐related leukaemia cutis: A review. Australasian Journal of Dermatology. 49(4). 187–190. 7 indexed citations
19.
20.
Marcoullis, George, et al.. (2002). Microangiopathic Hemolysis Refractory to Plasmapheresis Responding to Docetaxel and Cisplatin: A Case Report. Medical Oncology. 19(3). 189–192. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianfranco Zannoni Breakdown of academic impact, for papers by Xi Cheng Breakdown of academic impact, for papers by Shanique Martin Breakdown of academic impact, for papers by Silverio Tomao Breakdown of academic impact, for papers by Zhifeng Xi Breakdown of academic impact, for papers by Kakil Ibrahim Rasul Breakdown of academic impact, for papers by Musa Altun Breakdown of academic impact, for papers by Kohji Yoshida Breakdown of academic impact, for papers by Oxana V. Makarova‐Rusher Breakdown of academic impact, for papers by Giuseppa Scandurra
Rankless by CCL
2026